Editorial
With the growing number of cancer survivors, it is critical for us to
consider toxicities that arise during treatment and
do not resolve after treatment ends. Some symptoms
continue to burden patients for many years after the cancer has been
cured,
and chemotherapy-induced peripheral neuropathy (CIPN)
is a conspicuous example.....
..... We must be clinically attuned to the complaints our patients voice, and
we must make
a serious effort to develop prevention and treatment
strategies that will reduce the burden of cancer treatment–associated
toxicities.
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.